The Cost of Generalist Agencies: Why Your Biotech Website Needs Scientific Native Translation

Every biotech founder who has hired a general web agency knows the specific fatigue of the kickoff call. You have carved out time you did not have to explain your company, and instead of discussing how to present it, you are explaining the underlying science from the ground up. What a polymerase does. Why your assay is different from PCR. What "multiplex" means. The designer is smart and well-intentioned, taking careful notes, but they are learning your field in real time on your dime, and you are the textbook. By the end you have taught a short course in molecular biology and barely touched the actual website.

That friction is annoying, but it is not the real cost. The real cost arrives later, in the deliverable. Because no matter how good your explanation was, the person translating your science into copy and graphics does not actually understand it. They understand a compressed, lossy version assembled from a couple of calls. And when they sit down to write your technology page or design your mechanism figure, the gaps in that understanding become errors in your public-facing materials. Errors that you, busy running a company, may not catch, and that the scientifically literate people evaluating you absolutely will.

The translation layer is where meaning leaks out

The standard agency model puts a translation layer between your science and your website. You know the science. The agency does not. So everything has to pass from you, through their partial understanding, into the final product, and at every step some precision leaks out. A term gets used loosely. A causal relationship gets flipped. A carefully hedged claim becomes an overclaim because the writer did not register why the hedge was there. Individually these look minor. Collectively they produce a website that feels, to an expert reader, subtly off, in the way a translated document reads when the translator did not quite speak the source language.

And your audience is expert. Biotech websites are read by investors with science backgrounds, by scientific advisors doing diligence, by the researchers you want to recruit, by potential partners with deep domain knowledge. These are the least forgiving readers imaginable for scientific imprecision, because they cannot switch off the part of their brain that notices. When your site says a target is "proven" that should be "implicated," or draws a pathway backwards, they see it instantly. The translation errors you might not notice are precisely the ones your most important readers cannot miss.

Removing the layer changes the economics and the output

The alternative is to remove the translation layer entirely: have the person building the site already understand the science. This is not a marginal improvement to the same process. It changes what the process is. When the builder reads your papers and understands them, there is no kickoff course in molecular biology. There is a conversation between people who share a vocabulary, which is faster and higher-bandwidth in both directions. The time you would have spent teaching becomes time spent on what the site should actually say.

More importantly, the output has no translation errors, because there was no translation. The person writing the technology page is reasoning from an actual understanding of the mechanism, so the copy is precise by default. The person designing the mechanism figure knows which details are load-bearing, so the figure is correct by default. Accuracy stops being something you have to catch in review and becomes a property of the work as it is made. That is a categorically different relationship to your own materials than the anxious final-proofread most founders resign themselves to.

What "scientific native" actually means

Scientific native translation is not marketing language for a copywriter who read some articles. It means the person doing the work has genuinely operated in the domain: has been at the bench, has designed experiments, has developed the kinds of technologies your clients build. That background is not a credential to display. It is the thing that makes the difference between a site that merely looks scientific and one that is scientific, that holds up when the person reading it knows more than you hoped they would.

This is the entire premise of CodonForge, and it is described plainly on the about page and reflected in how every engagement is run. The builder already understands the science, so execution is faster and the final product contains no scientific errors introduced in translation, because there was no translation step to introduce them. You are not hiring someone to learn your field. You are working with someone who already lives in it.

The generalist agency is not incompetent. It is simply the wrong tool for a job where the audience is expert and the margin for scientific error is zero. For most industries, a talented generalist is exactly right. For biotech, where your readers can see straight through imprecision to the understanding behind it, the person building your site should understand your science as well as you do. Anything less shows, and it shows to the people you least want to lose.